Quantitative cerebral MR perfusion imaging: preliminary results in stroke.
Quantitative cerebral MR perfusion imaging: preliminary results in stroke.
复制标题
DOI:
10.1002/jmri.22302
复制
发表时间:
2010-10
影响因子:
4.4
通讯作者:
Carroll, Timothy J.
中科院分区:
文献类型:
--
作者:
Shah, Maulin K.;Shin, Wanyong;Parikh, Vishal S.;Ragin, Ann;Mouannes, Jessy;Bernstein, Richard A.;Walker, Matthew T.;Bhatt, Hem;Carroll, Timothy J.
To evaluate quantitative cerebral blood flow (qCBF) with traditional time-based measurements or metrics of cerebral perfusion: time to peak (Tmax) and mean transit time (MTT) in stroke patients. Nine ischemic stroke patients (4 Male, 5 Female, 63±16 years old) were included in the study which was HIPAA compliant and institutional review board approved. Cerebral perfusion was quantified using the Bookend method. Mean values of qCBF, Tmax, and MTT were determined in regions of interest (ROIs). ROIs were drawn on diffusion weighted images in diffusion positive, critically ischemic (CI), in ipsilateral normal region immediately surrounding the critically ischemic region, the presumed penumbra (PP), and in contralateral diffusion negative control, presumed normal region (PN) of gray and white matter separately (GM and WM). In both GM and WM, qCBF measures distinguished the studied brain regions with the most markedly reduced values in regions corresponding to extent of likely ischemic injury. In planned comparisons, only qCBF measurements differed significantly between CI and PP tissues. ROC analysis supported the utility of qCBF for discriminating brain regions differing in the likely extent of ischemic injury (CI and PN regions – qCBF: AUC=0.96, Tmax: AUC=0.96, MTT: AUC=0.72). Importantly, qCBF afforded the best discrimination of CI and PP regions (qCBF: AUC=0.82, Tmax: AUC=0.65, MTT: AUC=0.52). This initial evaluation indicates that quantitative MRI perfusion is feasible in ischemic stroke patients. qCBF derived with this strategy provide enhanced discrimination of CI and PP compared to time-based imaging metrics. This approach merits investigation in larger clinical studies.
登录
查看更多内容
影响因子:
14.5
作者:
LEENDERS, KL;PERANI, D;JONES, T
通讯作者:
JONES, T
影响因子:
4.4
作者:
Lin, W;Celik, A;Powers, WJ
通讯作者:
Powers, WJ
影响因子:
9.9
作者:
Hakim, AM
通讯作者:
Hakim, AM
影响因子:
5
作者:
Obuchowski, NA
通讯作者:
Obuchowski, NA
DOI:
10.1097/00004647-199809000-00002
发表时间:
1998-09-01
影响因子:
6.3
作者:
Ostergaard, L;Johannsen, P;Gyldensted, C
通讯作者:
Gyldensted, C